Pages that link to "Q42246428"

The following pages link to Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-κB-dependent pathways (Q42246428):

Displaying 42 items.

• Neuroprotective mechanisms of the ACE2-angiotensin-(1-7)-Mas axis in stroke (Q26998948) (← links)
• Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway (Q28565300) (← links)
• Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice (Q33773490) (← links)
• Chronic treatment with Ang-(1-7) reverses abnormal reactivity in the corpus cavernosum and normalizes diabetes-induced changes in the protein levels of ACE, ACE2, ROCK1, ROCK2 and omega-hydroxylase in a rat model of type 1 diabetes (Q34275725) (← links)
• Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor (Q34500492) (← links)
• Angiotensin-(1-7) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas/eNOS-dependent pathway (Q34559574) (← links)
• G-protein coupled receptors of the renin-angiotensin system: new targets against breast cancer? (Q35089791) (← links)
• Chronic ANG II infusion induces sex-specific increases in renal T cells in Sprague-Dawley rats (Q35274058) (← links)
• Topical administration of diminazene aceturate decreases inflammation in endotoxin-induced uveitis (Q35386325) (← links)
• Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation (Q35484382) (← links)
• Anti-Inflammatory Action of Angiotensin 1-7 in Experimental Colitis (Q35952628) (← links)
• Expression of MAS1 in breast cancer (Q36092905) (← links)
• Activation of angiotensin II type 2 receptor suppresses TNF-α-induced ICAM-1 via NF-кB: possible role of ACE2 (Q36114299) (← links)
• Dose-dependent, therapeutic potential of angiotensin-(1-7) for the treatment of pulmonary arterial hypertension (Q36352087) (← links)
• ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis (Q36929414) (← links)
• Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury (Q37147092) (← links)
• AAV8-Mediated Angiotensin-Converting Enzyme 2 Gene Delivery Prevents Experimental Autoimmune Uveitis by Regulating MAPK, NF-κB and STAT3 Pathways (Q37202385) (← links)
• Role of the receptor Mas in macrophage-mediated inflammation in vivo. (Q37493351) (← links)
• Angiotensin-(1-7): beyond the cardio-renal actions. (Q38068237) (← links)
• Cerebroprotective action of angiotensin peptides in stroke. (Q38150360) (← links)
• Molecular and cellular mechanisms of the inhibitory effects of ACE-2/ANG1-7/Mas axis on lung injury (Q38543053) (← links)
• Macrophages in neuroinflammation: role of the renin-angiotensin-system. (Q38965333) (← links)
• Chronic allergic pulmonary inflammation is aggravated in angiotensin-(1-7) Mas receptor knockout mice. (Q39213904) (← links)
• Src-dependent EGFR transactivation regulates lung inflammation via downstream signaling involving ERK1/2, PI3Kδ/Akt and NFκB induction in a murine asthma model (Q41565956) (← links)
• Suppressing inflammation by inhibiting the NF-κB pathway contributes to the neuroprotective effect of angiotensin-(1-7) in rats with permanent cerebral ischaemia (Q42098732) (← links)
• AVE 0991, a non-peptide mimic of angiotensin-(1-7) effects, attenuates pulmonary remodelling in a model of chronic asthma. (Q42686839) (← links)
• Angiotensin-(1-7) is Reduced and Inversely Correlates with Tau Hyperphosphorylation in Animal Models of Alzheimer's Disease (Q46152975) (← links)
• Angiotensin-(1-7)-mediated Mas1 receptor/NF-κB-p65 signaling is involved in a cigarette smoke-induced chronic obstructive pulmonary disease mouse model (Q47726786) (← links)
• The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7). (Q47851502) (← links)
• Angiotensin-(1-7) via the mas receptor alleviates the diabetes-induced decrease in GFAP and GAP-43 immunoreactivity with concomitant reduction in the COX-2 in hippocampal formation: an immunohistochemical study (Q48468401) (← links)
• Angiotensin-(1-7) Promotes Resolution of Neutrophilic Inflammation in a Model of Antigen-Induced Arthritis in Mice (Q49494516) (← links)
• Angiotensin-(1-7) Inhibits Thrombin-Induced Endothelial Phenotypic Changes and Reactive Oxygen Species Production via NADPH Oxidase 5 Downregulation (Q49631904) (← links)
• Angiotensin-(1-7) Promotes Resolution of Eosinophilic Inflammation in an Experimental Model of Asthma (Q49727272) (← links)
• The dual targeting of EGFR and ErbB2 with the inhibitor Lapatinib corrects high glucose-induced apoptosis and vascular dysfunction by opposing multiple diabetes-induced signaling changes (Q50959754) (← links)
• Expression of the Mas receptor is upregulated in skeletal muscle wasting. (Q54192199) (← links)
• Angiotensin-(1-7) attenuates organ injury and mortality in rats with polymicrobial sepsis (Q58110454) (← links)
• Angiotensin-(1-7) and the Regulation of Anti-Fibrotic Signaling Pathways (Q88481204) (← links)
• Muscle wasting: A review of exercise, classical and non-classical RAS axes (Q91627444) (← links)
• 18F-Trifluoromethanesulfinate Enables Direct C-H 18F-Trifluoromethylation of Native Aromatic Residues in Peptides (Q92493339) (← links)
• The pivotal link between ACE2 deficiency and SARS-CoV-2 infection (Q93237239) (← links)
• Mesenchymal stromal cells and their secreted extracellular vesicles as therapeutic tools for COVID-19 pneumonia? (*) (Q97082908) (← links)
• The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19 (Q97526965) (← links)